Area physicians accept thousands from drug companies for speaking, other expenses
In 2010, pharmaceutical company Novartis paid Grand Forks neurologist Dr. Matthew Roller $4,550 to talk about its drug Gilenya, the first oral medication approved for treating multiple sclerosis.
Before that medication, multiple sclerosis was treated via injection — a method patients weren’t fond of, according to Roller.
Are you a newspaper subscriber but you don't have a Digital Access account yet? Activate your account.
You will need your subscription account number and phone number. Not sure if you have an account? Email us or call (701) 780-1100 and we can help you.